Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
41851-59-6COc1ccc([C@H](C)N)cc1JTDGKQNNPKXKII-ZETCQYMHSA-N41851-59-6、6298-96-0DTXSID00355183Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302 (72.3%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P333+P317, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 155 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden(S)-()-4-Methoxy-α-methylbenzylamine is employed in the synthesis of S(+)-4-(1-phenylethylamino)quinazolines, as human immunoglobuline E inhibitor and haloaryl-β-amino acids. It is also used as a precursor to prepare chiral intermediate in the total synthesis of solanoeclepin A.